[1] FIRE A，XU S，MONTGOMER M K，et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J]. Nature，1998，391（6669）：806-811. [2] ELBASHIR S M，LENDECKEL W，TUSCHL T. RNA interference is mediated by 21-and 22-nucleotide RNAs[J]. Genes Dev，2001，15(2)：188-200. [3] ELBASHIR S M，HARBORTH J，LENDECKEL W，et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells [J]. Nature，2001，411（6836）：494-498. [4] FRANK Y，MARTIN C W，LU P Y. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development [J]. DDT，2006，11(1/2)：67-72. [5] MARTIN C W，LU P Y. Nanoparticles delivery RNAi therapy [J]. Nanotoday，2005，8(8)：34-41. [6] SUN L P，WONG J，ZHANG X M，et al. Chemical modification of siRNA and its clinical application[J]. Chem life(生命的化学)，2005，25(4)：339-342. [7] TOLENTINO M J，BRUCKER A J，FOSNOT J，et al. Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate，laser-induced model of choroidal neovascularization [J]. Retina，2004，24(1)：132-138. [8] DORN G，PATEL S，WOTHERSPOON G，et al. siRNA relieves chronic neuropathic pain [J]. Nucleic Acids Res，2004，32(5)：e49. [9] PILLE J Y，DENOYELLE C，VARET J，et al. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo [J]. Mol Ther，2005，11(2)：267-274. [10] BITKO V，MUSIYENKO A，SHULYAYEVA O，et al. Inhibition of respiratory viruses by nasally administered siRNA [J]. Nat Med，2005，11（1）：50-55. [11] MCCAFFREY A P，NAKIA H，PANDEY K，et al. Inhibition of hepatitis B virus in mice by RNA interference [J]. Nat Biotechnol，2003，21(6)：639-644. [12] GOLZIO M，MAZZOLINI L，MOLLER P，et al. Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery [J]. Gene Ther，2005，12（3）：246-251. [13] SOUTSCHEK J，AKINC A，BRAMLAGE B，et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs [J]. Nature，2004，432(7014)：173-178. [14] HALDER J，KAMAT A A，LANDEN C J，et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy [J]. Clin Cancer Res，2006，12(16)：4916-4924. [15] ARNOLD A S，TANG Y L，QIAN K，et al. Specific beta1-adrenergic receptor silencing with small interfering RNA lowers high blood pressure and improves cardiac function in myocardial ischemia [J]. J Hypertens，2007，25(1)：197-205. [16] PALLISER D，CHOWDHURY D，WANG Q Y，et al. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection [J]. Nature，2006，439(7072)：89-94. [17] MORRISSEY D V，LOCKRIDGE J A，SHAW L，et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs [J]. Nat Biotechnol，2005，23(8)：1002-1007. [18] ZIMMERMANN T S，LEE A C，AKINC A，et al. RNAi-mediated gene silencing in non-human primates [J]. Nature，2006，441(7089)：111-114. [19] GEISBERT T W，HENSLEY L E，KAGAN E，et al. Postexposure protection of guinea pigs against a lethal ebola virus challenge isconferred by RNA interference [J]. J Infect Dis，2006，193(12)：1650-1657. [20] VANDENBROUCKE R E，LENTACKER I，DEMEESTER J，et al. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles [J]. J Controlled Release，2008，126（3）：265-273. [21] PIROLLO K F，ZON G，RAIT A，et al. Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery[J]. Hum Gene Ther，2006，17(1)：117-124. [22] HOGREFE R I，LEBEDEV A V，ZON G，et al. Chemically modified short interfering hybrids(siHYBRIDS)：Nanoimmunoliposome delivery in vitro and in vivo for RNAi of HER-2 [J]. Nucleosides Nucleotides Nucleic Acids，2006，25(8)：889-907. [23] WATANABE T，UMEHARA T，YASUI F，et al. Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome [J]. J Hepatol，2007，47(6)：744-750. [24] SATO A，TAKAGI M，SHIMAMOTO A，et al. Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice [J]. Biomaterials，2007，28(7)：1434-1442. [25] ZHANG C L，TANG N，LIU X，et al. siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene [J]. J Controlled Release，2006，112(2)：229-239. [26] CHIEN P Y，WANG J，CARBONARO D，et al. Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo [J]. Cancer Gene Ther，2005，12(3)：321-328. [27] URBAN-KLEIN B，WERTH S，ABUHARBEID S，et al. RNAi-mediated gene-targeting through systemic application of polyethylenimine(PEI)-complexed siRNA in vivo [J]. Gene Ther，2005，12 (5)：461-466. [28] GE Q，FILIP L，BAI A，et al. Inhibition of influenza virus production in virus-infected mice by RNA interference [J]. Proc Natl Acad Sci USA，2004，101(23)：8676-8681. [29] ZINTCHENKO A，PHILIPP A，DEHSHAHRI A，et al. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity [J]. Bioconjugate Chem，2008，19（7）：1448-1455. [30] THOMAS M，LU J J，GE Q，et al. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse Lung [J]. Proc Acad Sci USA，2005，102(16)：5679-5684. [31] CREUSAT G，ZUBER G. Tyrosine-modified PEI：a novel and highly efficient vector for siRNA delivery in mammalian cells [J].Nucleic Acids Symp Ser(Oxf)，2008，52（1）：91-92. [32] SCHIFFELERS R M，ANSARI A，XU J，et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle [J]. Nucleic Acids Res，2004，32(19)：e149. [33] HOWARD K A，RAHBEK U L，LIU X，et al. RNA Interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system [J]. Mol Ther，2006，14(4)：476-484. [34] BITKO V，MUSIYENKO A，SHULYAYEVA O，et al. Inhibition of respiratory viruses by nasally administered siRNA[J]. Nat Med，2005，11(1)：50-55. [35] TAKESHITA F，MINAKUCHI Y，NAGAHARA S，et al. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo [J]. Proc Natl Acad Sci USA，2005，102(34)：12177-12182. [36] HU-LIESKOVAN S，HEIDEL J D，BARTLETT D W，et al. Sequence-specific knockdown of EWS-FLI1 by targeted，nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing’s sarcoma [J]. Cancer Res，2005，65（19）：8984-8992. [37] HEIDEL J D，YU Z，LIU C，et al. Administration in nonhuman primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA [J]. Proc Natl Acad Sci USA，2007，104（14）：5715-5721. [38] KIM S H，JEONG J H，LEE S H，et al. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy [J]. J Controlled Release，2006，116（2）：123-129. [39] KIM S H，JEONG J H，LEE S H，et al. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer [J]. J Controlled Release，2008，129（2）：107-116. [40] KIM S H，JEONG J H，LEE S H，et al. LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI [J]. Bioconjug Chem，2008，19（11）：2156-2162. [41] LEE S H，KIM S H，PARK T G. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide [J]. Biochem Biophys Res Commun，2007，357(2)：511-516. [42] ITAKA K，KANAYAMA N，NISHIYAMA N，et al. Supramolecular nanocarrier of siRNA from PEG-based block catiomer carrying diamine side chain with distinctive pKa dircted to enhance intracellular gene silencing [J]. J Am Chem Soc，2004，126(42)：13612-13613. [43] SONG E，ZHU P，LEE S K，et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors [J]. Nat Biotechnol，2005，23（6）：709-717. [44] MCNAMARA J O，ANDRECHEK E R，WANG Y，et al. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras [J]. Nat Biotechnol，2006，24（8）：1005-1015. [45] ZHOU J，LI H，LI S，et al. Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy [J]. Mol Ther，2008，16(8)：1481-1489. [46] LI B J，TANG Q，CHENG D，et al. Using siRNA in prophylactic and therapeutic regimens against SARS Coronavirus in Rhesus Macaque [J]. Nat Med，2005，11 (9)：944-951. [47] KUMAR P，WU H，MCBRIDE J L，et al. Transvascular delivery of small interfering RNA to the central nervous system [J]. Nature，2007，448（7149）：39-43. [48] MASSARO D，MASSARO G D，CLERCH L B. Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice [J]. Am J Physiol Lung Cell Mol Physiol，2004，287（5）：1066-1070.